It was a whale of a week for Litigator of the Week nominations. No offense to our prior winners, but the top four results I had sitting in front of me this week would have had a pretty darn good chance of taking home the honors in what I’ll call a more normal week.
Our first runner-up can boast of having scored the largest defense judgment in patent litigation history. (Gulp. Did I really just name these guys a runners up?) Mark Perry and Wayne Barsky of Gibson, Dunn & Crutcher scored a win at the Federal Circuit for clients Serono and Pfizer that brings an end to 10 years of litigation with rival Biogen. The Federal Circuit decision reinstates a jury finding that Biogen’s patent for a certain use of interferon-beta, a human protein that triggers the body to fight viral diseases, was anticipated in the prior art. The ruling wards off Biogen’s damages claim of more than $5.4 billion. That’s billion with a “B.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
